Haemonetics Corporation (HAE) recently announced the full market release of its VASCADE MVP XL — a mid-bore venous closure system. The VASCADE MVP XL system will now be available to U.S. hospitals as the newest addition to the company's VASCADE portfolio of vascular closure systems. With the full market release underway and an ongoing clinical trial program, the company is well-positioned to broaden the indications for the VASCADE MVP XL system to even larger access points. The latest development is expecte ...